Ensign Peak Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
69,850
-6,500
| -9% | -$109K | ﹤0.01% | 1151 |
|
|
2025
Q1 | $1.17M | Sell |
76,350
-5,850
| -7% | -$89.9K | ﹤0.01% | 1163 |
|
|
2024
Q4 | $1.81M | Hold |
82,200
| – | – | ﹤0.01% | 986 |
|
|
2024
Q3 | $1.48M | Hold |
82,200
| – | – | ﹤0.01% | 1095 |
|
|
2024
Q2 | $1.34M | Hold |
82,200
| – | – | ﹤0.01% | 1108 |
|
|
2024
Q1 | $1.16M | Hold |
82,200
| – | – | ﹤0.01% | 1221 |
|
|
2023
Q4 | $858K | Hold |
82,200
| – | – | ﹤0.01% | 1465 |
|
|
2023
Q3 | $838K | Hold |
82,200
| – | – | ﹤0.01% | 1329 |
|
|
2023
Q2 | $619K | Hold |
82,200
| – | – | ﹤0.01% | 1560 |
|
|
2023
Q1 | $727K | Buy |
82,200
+15,700
| +24% | +$139K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $606K | Buy |
66,500
+12,050
| +22% | +$110K | ﹤0.01% | 1552 |
|
|
2022
Q3 | $439K | Buy |
54,450
+7,050
| +15% | +$56.8K | ﹤0.01% | 1530 |
|
|
2022
Q2 | $356K | Buy |
47,400
+1,550
| +3% | +$11.6K | ﹤0.01% | 1607 |
|
|
2022
Q1 | $431K | Hold |
45,850
| – | – | ﹤0.01% | 1609 |
|
|
2021
Q4 | $367K | Buy |
45,850
+1,500
| +3% | +$12K | ﹤0.01% | 1740 |
|
|
2021
Q3 | $432K | Hold |
44,350
| – | – | ﹤0.01% | 1651 |
|
|
2021
Q2 | $439K | Buy |
44,350
+7,500
| +20% | +$74.2K | ﹤0.01% | 1615 |
|
|
2021
Q1 | $425K | Hold |
36,850
| – | – | ﹤0.01% | 1621 |
|
|
2020
Q4 | $356K | Hold |
36,850
| – | – | ﹤0.01% | 1651 |
|
|
2020
Q3 | $332K | Buy |
+36,850
| New | +$332K | ﹤0.01% | 1603 |
|